Oculus Innovative Sciences Announces Record Monthly and Quarterly Prescription Data
July 06, 2016 04:05 ET
|
Oculus Innovative Sciences, Inc.
May 2016: Highest Monthly Prescriptions Filled in Oculus’ History Quarter Ended March 31, 2016: Highest Quarterly Number of Prescriptions 34% over prior December quarter25% average “quarter over...
Oculus Innovative Sciences Announces Reverse Split of Common Stock
June 22, 2016 05:05 ET
|
Oculus Innovative Sciences, Inc.
PETALUMA, Calif., June 22, 2016 (GLOBE NEWSWIRE) -- Oculus Innovative Sciences, Inc. (NASDAQ: OCLS, warrants OCLSW), a specialty pharmaceutical company that develops and markets unique and...
Oculus Innovative Sciences Reports Financial Results for Fiscal Year 2016 and Fourth Quarter Ending March 31, 2016
June 16, 2016 16:05 ET
|
Oculus Innovative Sciences, Inc.
Product Revenue for Fiscal Year 2016 Grew 31% Led by Growth in U.S. Dermatology Conference Call Begins at 4:30pm EDT Today PETALUMA, Calif., June 16, 2016 (GLOBE NEWSWIRE) -- Oculus...
Oculus Innovative Sciences Announces Financial Results for the Fiscal Year/Fourth Quarter 2016 and Conference Call
June 02, 2016 04:05 ET
|
Sonoma Pharmaceuticals, Inc.
PETALUMA, Calif., June 02, 2016 (GLOBE NEWSWIRE) -- Oculus Innovative Sciences, Inc. (NASDAQ: OCLS, warrants OCLSW), today announced that the financial results for its fiscal year and fourth...
Oculus Innovative Sciences Launches New Ceramax™ Skin Barrier Cream in the United States
May 03, 2016 04:05 ET
|
Sonoma Pharmaceuticals, Inc.
PETALUMA, Calif., May 03, 2016 (GLOBE NEWSWIRE) -- Oculus Innovative Sciences, Inc. (NASDAQ: OCLS, warrants OCLSW), a specialty pharmaceutical company that develops and markets solutions for...
Oculus Innovative Sciences to Present at Pioneers 2016 Investor Conference Hosted by Joseph Gunnar & Company in New York City
April 28, 2016 04:05 ET
|
Sonoma Pharmaceuticals, Inc.
PETALUMA, Calif., April 28, 2016 (GLOBE NEWSWIRE) -- Oculus Innovative Sciences, Inc. (NASDAQ: OCLS, warrants OCLSW), a specialty pharmaceutical company that develops and markets solutions...
Oculus Innovative Sciences to Present at the Third Annual Growth Capital Expo MicroCap Investor Conference in Las Vegas
April 27, 2016 04:05 ET
|
Sonoma Pharmaceuticals, Inc.
PETALUMA, Calif., April 27, 2016 (GLOBE NEWSWIRE) -- Oculus Innovative Sciences, Inc. (NASDAQ:OCLS) (NASDAQ:OCLSW), a specialty pharmaceutical company that develops and markets solutions for...
Oculus Innovative Sciences Receives U.S. FDA Approval for Lasercyn™ for Use Following Laser Procedures, Microdermabrasions and Chemical Peels
April 20, 2016 04:05 ET
|
Sonoma Pharmaceuticals, Inc.
PETALUMA, Calif., April 20, 2016 (GLOBE NEWSWIRE) -- Oculus Innovative Sciences, Inc. (NASDAQ: OCLS, warrants OCLSW), a specialty pharmaceutical company that develops and markets solutions...
Oculus Innovative Sciences Receives European Approval to Market Sinudox™ Indicated for Use in Nasal Irrigation
April 13, 2016 04:05 ET
|
Sonoma Pharmaceuticals, Inc.
PETALUMA, Calif., April 13, 2016 (GLOBE NEWSWIRE) -- Oculus Innovative Sciences, Inc. (NASDAQ:OCLS) (NASDAQ:OCLSW), a specialty pharmaceutical company that develops and markets solutions for...
Oculus Innovative Sciences Strengthens Intellectual Property Portfolio With Allowance of New Patents for Microcyn® Technology
April 06, 2016 04:05 ET
|
Sonoma Pharmaceuticals, Inc.
PETALUMA, Calif., April 06, 2016 (GLOBE NEWSWIRE) -- Oculus Innovative Sciences, Inc. (NASDAQ:OCLS) (NASDAQ:OCLSW), a specialty pharmaceutical company that develops and markets solutions for the...